2017-03-01,ProQR To Present At Two Upcoming Investor Conferences In March
2017-02-28,ProQR Announces Results For The Fourth Quarter And Full Year 2016 And Provides A Business Update
2017-02-27,On A Shared Quest To Find Treatments For Rare Diseases, ProQR Supports Rare Disease Day
2017-02-09,These 5 Stocks Under $10 Could Explode Up Soon
2017-02-07,ProQR To Present At The LEERINK Partners Global Healthcare Conference
2016-11-14,ProQR Announces Results For The Third Quarter Of 2016
2016-11-02,ProQR Therapeutics Enters Oversold Territory (PRQR)
2016-10-27,ProQR Cystic Fibrosis Drug Passes First, Early Efficacy Test
2016-10-27,ProQR Announces That QR-010 Meets The Primary Endpoint In A Proof Of Concept Study Of Homozygous F508del Cystic Fibrosis Patients
2016-09-27,ProQR Announces Clinical Data Presentations And Investor & Analyst Event At NACFC
2016-09-06,ProQR To Present At Scientific And Investor Conferences In September
2016-08-17,ProQR Announces Results For The Second Quarter Of 2016
2016-07-19,ProQR Receives Fast Track Designation From FDA For QR-010 For Cystic Fibrosis
2016-06-21,ProQR To Release Topline Data From Proof Of Concept Study Of QR-010 In Cystic Fibrosis Patients At NACFC
2016-06-01,ProQR's Drug Candidate QR-110 For Leber's Congenital Amaurosis Type 10 Receives EMA And FDA Orphan Drug Designation
2016-06-01,ProQR Announces Presentations At The European CF Conference And The JMP Life Science Conference
2016-05-18,ProQR Announces Results For The First Quarter Of 2016
2016-04-25,ProQR Announces An Investor And Analyst Event And Pre-Clinical Data Presentations For QR-110 For LCA10 At The 2016 ARVO Annual Meeting
2016-04-07,ProQR Announces Annual Meeting Of Shareholders
2016-03-11,Ratings Changes Today
2016-03-01,ProQR To Highlight A Growing Pipeline During A Research & Development Day And Present At The Barclays Global Healthcare Conference
2016-02-17,ProQR Announces Results For The Fourth Quarter And Full Year 2015
2016-02-03,ProQR To Present At The Leerink Partners Global Healthcare Conference
2015-12-31,5 Stocks Under $10 Set to Soar
2015-12-17,Oversold Conditions For ProQR Therapeutics (PRQR)
2015-11-30,ProQR Announces R&D Day And Provides Update On Innovation Portfolio
2015-11-23,ProQR Therapeutics Becomes Oversold (PRQR)
2015-11-23,ProQR Announces Results For The Third Quarter Of 2015 And Provides Update On Clinical Trials
2015-10-08,Vertex to Test New Cystic Fibrosis Drugs, Seeking Broader, More Effective Treatments
2015-10-01,ProQR Announces An Investor And Analyst Event And Pre-Clinical Data Presentations For QR-010 For Cystic Fibrosis At Two Upcoming Scientific Conferences
2015-09-23,ProQR To Present At The Leerink Partners 4th Annual Rare Disease Roundtable
2015-09-14,ProQR Announces A Proof-of-Concept Nasal Potential Difference Study Of QR-010 Is Open For Enrollment
2015-08-19,ProQR Announces Results For The Second Quarter Of 2015
2015-07-08,ProQR Therapeutics Becomes Oversold (PRQR)
2015-06-26,ProQR Announces Enrollment Has Started In Global Phase 1b Study Of QR-010 In Cystic Fibrosis Patients
2015-06-16,ProQR To Present At The JMP Securities Life Science Conference
2015-05-21,ProQR Therapeutics Announces Results For The First Quarter Of 2015
2015-04-29,ProQR To Present At Two Upcoming Investor Conferences In May
2015-04-29,ProQR Therapeutics Announces Annual Shareholder Meeting
2015-02-26,ProQR Therapeutics Announces Results For The Fourth Quarter And Full Year 2014
2015-02-04,ProQR To Present At The 2015 Leerink Global Healthcare Conference
2014-11-24,ProQR Therapeutics Announces Results For The Third Quarter Of 2014
2014-09-26,Biotech Stock Mailbag: ProQR, Vertex Pharma, Tekmira, Agios
2014-09-23,ProQR Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares
2014-09-18,ProQR Announces Pricing Of Initial Public Offering
,
,
,
,
